Archives
FLOT1–FOSL2–EphA2 Signaling in Alzheimer’s Disease
2026-09-10
A 2026 Neuropharmacology study identifies a FLOT1–FOSL2–EphA2 regulatory axis that activates p38/MAPK signaling and promotes pro-inflammatory microglial polarization in Alzheimer’s disease models. The findings connect a membrane-associated scaffold protein with transcriptional control, neuroinflammation, and cognitive performance, while suggesting a pathway for mechanistic intervention.
Alexa Fluor 488 Conjugated Secondary Antibody
2026-09-10
A practical, scenario-driven guide to using HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody, SKU K1214, in fluorescence-based viability, proliferation, cytotoxicity, and hypoxia workflows. It explains species compatibility, optical settings, controls, storage, interpretation, and evidence-based reagent selection without overstating product validation.
SLC25A1, Senescence, and HNSCC Cisplatin Resistance
2026-09-09
A 2026 npj Precision Oncology study identifies SLC25A1 as a metabolic and epigenetic regulator of cisplatin resistance in head and neck squamous cell carcinoma. The work connects mitochondrial citrate transport, cytosolic acetyl-CoA, H3K27ac-dependent transcription, and cellular senescence, while supporting SLC25A1 inhibition as a strategy for further preclinical investigation.
L-NMMA acetate for NOS Pathway Studies
2026-09-09
L-NMMA acetate provides a practical pan-NOS perturbation for testing whether nitric oxide signaling drives cell viability, osteogenic differentiation, or downstream cGMP responses. This workflow combines pathway inhibition with orthogonal readouts, helping distinguish mechanism from nonspecific toxicity in biochemical and pharmacological experiments.
Broad-Spectrum Bivalent mRNA Vaccine: Preclinical Evidence
2026-09-08
The reference study characterizes RQ3025, a bivalent mRNA vaccine designed around conserved and recurrent SARS-CoV-2 spike mutations, across several animal models. Its broad neutralization, variant protection, Th1-skewed cellular response, and favorable histology findings support further development while leaving important questions about durability, human translation, and variant coverage.
Diuron Workflows for Plant and Renal Toxicology
2026-09-08
Use Diuron as a controlled photosynthesis inhibitor for plant assays and as a mechanistic toxicology probe for renal injury models. This workflow connects compound handling, cell-based endpoints, and JAK2/STAT1-focused validation while addressing solubility, solvent, and reproducibility challenges.
EdU Imaging Kits (HF594): Practical Workflow
2026-09-07
EdU Imaging Kits (HF594), SKU K2243, support S-phase DNA synthesis measurement in fluorescence microscopy and flow cytometry workflows. They are appropriate for cell proliferation assays and related pharmacodynamic or genotoxicity studies, but EdU signal should not be treated as a standalone measure of viability, DNA damage, or complete cell-cycle state.
AG-126 for ERK–Striatal Assay Design
2026-09-07
AG-126 and Tyrphostin AG-126 offer a reversible way to test ERK1/2 signaling in striatal and inflammatory models. This article translates Neuroligin 1–D2-MSN findings into a rigorous assay strategy while separating established evidence from exploratory mechanisms.
Isoproterenol Sulfate Dihydrate in SAN Assays
2026-09-05
Isoproterenol sulfate dihydrate provides a controlled beta-adrenergic challenge for human sinoatrial node and cardiac assembloid research. This guide explains how to use the compound to separate receptor responsiveness from neuro-pacemaker maturation and interpret electrophysiological, cAMP, and metabolic readouts.
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody
2026-09-04
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody detects goat-derived IgG primary antibodies in fluorescence-based ICC/IF, IHC, flow cytometry, and ELISA workflows. It should not be used as a general secondary for non-goat primaries, and assay-specific titration and controls are required because no directly matched paper evidence is available here.
2,7-Dichlorodihydrofluorescein diacetate: ROS Workflow
2026-09-04
Build more reliable intracellular ROS measurements with DCFH-DA across microscopy, flow cytometry, and plate assays. This practical guide connects redox readouts to the melatonin–autophagy findings reported in hypertrophic-scar fibroblasts while emphasizing controls, optimization, and probe limitations.
From HBTU Coupling to Live-Cell Probe Insight
2026-09-03
HBTU connects controlled peptide assembly with emerging immunoproteasome activity assays. This thought-leadership perspective explains how its coupling chemistry can support caged bioluminescent probe workflows while keeping translational claims aligned with the current evidence.
Rational Design of IR-1061 NIR-II Liposomes
2026-09-03
Yu and colleagues developed a charge- and loading-aware liposomal system for improving the fluorescence performance of IR-1061 in NIR-II imaging. Their results show that phospholipid electrostatics and dye concentration jointly control encapsulation, molecular aggregation, vascular brightness, and long-circulation angiography in mice.
Isoproterenol Sulfate Dihydrate in SAN Assays
2026-09-02
Isoproterenol sulfate dihydrate provides a controlled pharmacological challenge for dissecting beta-adrenergic responses in human sinoatrial node models. This article shows how to distinguish acute cAMP/PKA pathway activation from longer-term neuro-pacemaker maturation in SAN–plexus assembloids.
Caspase-3, NDUFS1, and ROS in Trichothecene Liver Injury
2026-09-02
This preprint identifies a caspase-3/NDUFS1 pathway that links trichothecene exposure to mitochondrial complex I disruption and excessive ROS accumulation, while also implicating ER-localized ERO1α as a second oxidative source. Its combined in vivo, in vitro, pharmacological, expression-based, and mutation-focused design provides a framework for studying toxin-induced mitochondrial dysfunction, although the findings remain preliminary because the work has not undergone peer review.
742 records 8/50 page Previous Next First page 上5页 678910 下5页 Last page